Prime Medicine PRME Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's retained earnings?
- Prime Medicine (PRME) reported retained earnings of -$937.48M in Q1 2026.
- How has Prime Medicine's retained earnings changed year-over-year?
- Prime Medicine's retained earnings decreased by 26.8% year-over-year, from -$739.1M to -$937.48M.
- What is the long-term trend for Prime Medicine's retained earnings?
- Over 4 years (2021 to 2025), Prime Medicine's retained earnings has grown at a 50.9% compound annual growth rate (CAGR), from -$171.38M to -$888.35M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.